Literature DB >> 1705343

Aortic regurgitation during systole: color flow mapping and Doppler interrogation following the Damus-Kaye-Stansel procedure.

R M Giuffre1, N N Musewe, J F Smallhorn, R M Freedom.   

Abstract

Echocardiographic evidence of systolic aortic regurgitation following a Damus-Kaye-Stansel procedure for palliation of complex double-outlet right ventricle is presented. This procedure directs left ventricular output to the aorta through a proximal main pulmonary artery-aortic anastomosis and utilizes a valved conduit between the right ventricle and distal pulmonary artery. Postoperative Doppler and color flow echocardiographic findings revealed systolic and diastolic regurgitation from the native aorta to the right ventricle. Aortic valve closure at the time of the original Damus-Kaye-Stansel procedure would eliminate regurgitant flow and circumvent subsequent closure of this valve due to increased systolic aortic regurgitation.

Entities:  

Mesh:

Year:  1991        PMID: 1705343     DOI: 10.1007/BF02238500

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  A new operation for d-loop transposition of the great vessels.

Authors:  H C Stansel
Journal:  Ann Thorac Surg       Date:  1975-05       Impact factor: 4.330

2.  Anatomic correction of transposition of great arteries.

Authors:  M P Kaye
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

3.  The Damus-Stansel-Kaye procedure. Should the aortic valve or subaortic valve region be closed?

Authors:  S Y DeLeon; F S Idriss; M N Ilbawi; A J Muster; M H Paul; T E Berry; C E Duffy; J Quinones
Journal:  J Thorac Cardiovasc Surg       Date:  1986-05       Impact factor: 5.209

4.  Results of the Damus-Stansel-Kaye procedure for transposition of the great arteries and for double-outlet right ventricle with subpulmonary ventricular septal defect.

Authors:  E L Ceithaml; F J Puga; G K Danielson; D C McGoon; D G Ritter
Journal:  Ann Thorac Surg       Date:  1984-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.